Скачать или смотреть SA-XV: New Peptide REVOLUTIONIZING Fungal Keratitis Research

Discover SA-XV, a groundbreaking peptide poised to transform fungal keratitis research and address a critical global health challenge. Join Sonia Rao on Clinical Cadence as we delve into SA-XV, a novel 15-residue peptide developed collaboratively in India. This exciting breakthrough in peptide science offers a dual-action mechanism: not only acting as a potent antifungal against Fusarium and Candida (including difficult-to-treat biofilms), but also promoting corneal wound healing in research models. We explore its unique properties, compelling preclinical data published in JBC, and why it represents a significant unmet medical need compared to toxic current treatments like Amphotericin B. Learn about the complex journey from laboratory discovery to potential investigational use, including GLP studies, IND submissions, and future clinical trials, and understand its vast market potential. This video provides vital insights for researchers tracking peptide development and drug discovery for ocular infections. Please note: All compounds discussed are for research use only and not for human consumption. Always consult a licensed healthcare provider for medical needs.
#SAXV #PeptideResearch #FungalKeratitis #DrugDiscovery #Biotechnology